Bessent Signals Substantial Disinflation as Warsh Prepares to Lead the Federal Reserve Micron Extends Rally Amid AI Chip Momentum as US Markets Edge Higher on May 27 UK Police Chiefs Propose Blocking Unsafe Social Media for Under16s Raising Regulatory Risks for Tech Firms US Productivity Growth Slows in Q4 Unit Labor Costs Rise Sharply South Koreas Deputy PM Warns AI Wealth Must Benefit Public Amid Samsung Labor Tensions Genpact CEO Indicates Artificial Intelligence Could Reduce IT Workload and Reshape Industry Employment CUBB Q1 2026 Earnings Earnings Beat Expectations as Customers Bancorp Reports EPS of 197 SBLK Q1 2026 Earnings Strong EPS Beat Amid Dry Bulk Headwinds ANIX Q1 2026 Earnings Narrowed Loss Beats Expectations as Pipeline Advances Targa Resources Q1 2026 Earnings EPS Misses Estimates Amid Operational Strength FCN Q1 2026 Earnings EPS Misses Estimates Amid Slight Stock Uplift HDB Q1 2026 Earnings Solid EPS Beat Amid Steady Operational Performance Neuberger Next Generation Connectivity Fund Inc NBXG Surges 207 Testing Key Resistance Levels Parke Bancorp PKBK Edges Higher Amid Steady Trading Support and Resistance in Focus Neuberger Next Generation Connectivity Fund Inc NBXG Surges 207 Testing Key Resistance Levels J and Friends Holdings JF Holds Steady at 101 Amid Tight Trading Range CO2 Energy Transition Corp Right NOEMR Plunges 24 as Investors Assess Support Levels Stardust Power Inc SDST Q1 2026 Earnings EPS Misses Estimates as PreRevenue Company Focuses on Development CAPL Q1 2026 Earnings Strong EPS Surprise Despite Challenging Environment Kayne Anderson BDC Inc KBDC Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response ChargePoint Holdings CHPT Q1 2026 Earnings NarrowerThanExpected Loss Fuels Positive Market Response SUZ Q1 2026 Earnings Strong EPS Surprise Amid Market Concerns Amplitech Group Inc AMPGR Q1 2026 Earnings EPS Misses Estimates Amid Stock Surge Endurance Technologies IPO Opens Key Details and Market Expectations Asana ASAN Q1 2026 Earnings EPS Beat Drives Modest Stock Uptick Damora Therapeutics DMRA Gains 24 as Biotech Sector Finds Footing